All Updates

All Updates

icon
Filter
Funding
Nevia Bio raises USD 3.1 million in seed funding
Preventive Healthcare
Aug 29, 2023
This week:
Product updates
Hexagon unveils Advanced Compensation for metal 3D printing
Additive Manufacturing
Yesterday
Funding
Eden AI raises EUR 3 million in seed funding to accelerate product development
Generative AI Infrastructure
Nov 21, 2024
M&A
Wiz acquires Dazz to expand cloud security remediation capabilities
Next-gen Cybersecurity
Nov 21, 2024
Partnerships
Immutable partners with Altura to enhance Web3 game development and marketplace solutions
Web3 Ecosystem
Nov 21, 2024
Funding
OneCell Diagnostics raises USD 16 million in Series A funding to enhance cancer diagnostics
Precision Medicine
Nov 21, 2024
Partnerships
BioLineRx and Ayrmid partner to license and commercialize APHEXDA across multiple indications
Precision Medicine
Nov 21, 2024
Product updates
SOPHiA GENETICS announces global launch of MSK-IMPACT powered with SOPHiA DDM
Precision Medicine
Nov 21, 2024
Product updates
Biofidelity launches Aspyre Clinical Test for lung cancer detection
Precision Medicine
Nov 21, 2024
Partnerships
Spendesk partners with Adyen to enhance SMB spend management with banking-as-a-service solution
Business Expense Management
Nov 21, 2024
M&A
Mews acquires Swedish RMS provider Atomize to enhance Hospitality Cloud platform
Travel Tech
Nov 21, 2024
Preventive Healthcare

Preventive Healthcare

Aug 29, 2023

Nevia Bio raises USD 3.1 million in seed funding

Funding

  • Israel-based company Nevia Bio, formerly known as Gina Life, has raised USD 3.1 million in a seed funding round led by MindUP Digital Health Incubator, with participation from Pitango HealthTech, Alive Israel HealthTech Fund, the Technion investment arms, and other existing investors. This brings a total fund of USD 5 million.

  • The funding will be used to advance clinical trials for its lead ovarian cancer program, which decodes biomarker data from vaginal secretions for early detection. It will also support the broadening of the range of solutions in women's health and strengthen the company's capabilities in data science. 

  • Nevia is a FemTech company that has developed a platform designed to interpret biomarker data found in vaginal secretions. The company uses machine learning and data science techniques to identify unique biomarkers, which enable the early detection of diseases affecting women. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.